Active year completing acquisitions in Truehelm Fund II and Truehelm Fund III portfolios
Truehelm, f/k/a TT Capital Partners or TTCP, had an active year from an M&A perspective in both its 2018 vintage Fund II and 2022 vintage Fund III, completing six acquisitions. These acquisitions offer the opportunity to scale by adding capabilities, customers, and/or geographic markets.
InformedDNA
Truehelm Fund II portfolio company, InformedDNA, acquired Coriell Life Sciences in March 2025. Coriell combines pharmacogenomics (the study of how genes affect an individual’s response to medication) and precision medicine (tailored diagnosis and treatment plans specific to each patient) to help providers and payers understand how patients will respond to various medications, enabling improved patient outcomes and more efficient disease treatment. In combination with InformedDNA’s industry-leading genetic test interpretation and counseling services, the two create a platform that expands patient, provider, and payer access to genetic insights, driving better outcomes and cost savings through an individualized approach to care.
IDNA provides an industry-leading genetic test interpretation and counseling service, and this acquisition expands both the available tests and allows the company to provide more personalized, data-driven counseling insight.
See the press release detailing the acquisition.
Cantata Health Solutions
In March 2025, Truehelm Fund III portfolio company, Cantata Health Solutions, acquired New York-based IMA Systems. Cantata is a leading provider of EHR and other technology solutions for behavioral health and human service providers, serving nonprofit and private-sector organizations to enable the delivery of exceptional care. IMA Systems is a software company with over thirty years of experience providing specialty technology solutions to 35 customers in the New York market. The acquisition represents Cantata’s commitment to meeting the unique requirements of New York-based behavioral health providers.
Please click here if you’d like to view Cantata Health Solutions’ CEO, Alan Tilinghast’s, blog post regarding Cantata and how it is disrupting a market in need of innovative solutions serving providers. See the press release related to the acquisition of IMA Services.
Pyx Health
In June 2025, Truehelm Fund III company Pyx Health acquired FarmboxRx. The acquisition expands Pyx Health’s ability to engage health plan members by adding nutrition delivery capabilities, enabling the company to address food insecurity and other gaps in care.
Pyx Health provides a digital technology platform designed to support health plan quality efforts by engaging high-risk, hard-to-reach members. Since TTCP’s investment in 2023, Pyx Health has evolved from a point solution addressing loneliness and social isolation to an engagement platform solution supporting health plan quality initiatives. The company engages members with a blend of personalized technology, real human connection, and home-delivered nutrition resources that identify risks, close gaps in care, and address unmet needs to drive improved outcomes and quality scores.
Please see the press release related to this acquisition. Truehelm CEO Dawn Owens provided key insights regarding how Pyx is serving members in need of intervention and support in this interview. If you’d like to learn more about Pyx, click here for insights from Co-Founder and CEO, Cindy Jordan.
MacroHealth
Truehelm Fund II portfolio company MacroHealth made two acquisitions in June and July 2025, augmenting its offering to payer clients. MacroHealth is a healthcare technology company offering an intelligent healthcare marketplace for payers and their vendor partners. Its unique solution allows health insurance companies to optimize their system of providers and networks creating efficiency and transparent pricing. One of the acquisitions, Foundational Pharmacy, brings MacroHealth into the pharmacy benefit management sector. The second was responsive to customer needs; the acquisition of ClearCost Health improves MacroHealth’s capabilities providing pricing transparency in healthcare.
Please see the press release regarding Foundational Pharmacy and the press release regarding the acquisition of ClearCost Heath for additional information.
In addition, if you’d like to learn more about MacroHealth, see insights from Macro Health Co-Founder and CEO Virgil Bretz and Chief Growth Officer, Aarti Karamchandani.
Propio Language Services
Truehelm Fund II portfolio company Propio Language Services acquired CyraCom International, Inc. in July 2025. CyraCom was one of the world’s largest remote interpretation providers with a specialization serving healthcare clients, further expanding Propio’s ability to provide efficient, high-quality access to healthcare interpreting services. CyraCom was founded over 30 years ago with expertise in phone- and video-based interpretative services. Additional information regarding the acquisition is available here.
Propio Language services is the second largest by revenue remote language interpretation services company in the world, coupling high-quality human expertise with advanced technology to support interpretation, translation, and other needs. Propio leverages a network of over 20,000 linguists to service 300+ languages for healthcare and other highly regulated industries.